H R Williams

3.9k total citations
19 papers, 1.2k citations indexed

About

H R Williams is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, H R Williams has authored 19 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Cancer Research and 3 papers in Oncology. Recurrent topics in H R Williams's work include Protease and Inhibitor Mechanisms (6 papers), Peptidase Inhibition and Analysis (3 papers) and Erythrocyte Function and Pathophysiology (2 papers). H R Williams is often cited by papers focused on Protease and Inhibitor Mechanisms (6 papers), Peptidase Inhibition and Analysis (3 papers) and Erythrocyte Function and Pathophysiology (2 papers). H R Williams collaborates with scholars based in United States, Canada and Sweden. H R Williams's co-authors include Jeffrey R. Weidner, Michael W. Lark, Richard A. Mumford, E K Bayne, Irwin Singer, Susan Donatelli, Tsau-Yen Lin, Coral Harper, Stefan Lohmander and Lori A. Hoerrner and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

H R Williams

19 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H R Williams United States 11 438 392 336 245 234 19 1.2k
E. R. Pettipher United States 24 473 1.1× 691 1.8× 171 0.5× 261 1.1× 287 1.2× 31 1.8k
P.K. Chiang United States 11 558 1.3× 175 0.4× 126 0.4× 165 0.7× 92 0.4× 25 977
Anne M. Fourie United States 18 677 1.5× 547 1.4× 343 1.0× 421 1.7× 321 1.4× 32 2.0k
Alan H. Davidson United Kingdom 17 588 1.3× 87 0.2× 606 1.8× 448 1.8× 224 1.0× 43 1.7k
Julia M. Ayala United States 18 464 1.1× 126 0.3× 145 0.4× 278 1.1× 108 0.5× 22 1.1k
Geethani Bandara United States 23 709 1.6× 350 0.9× 80 0.2× 156 0.6× 241 1.0× 42 1.7k
Kary A. Latham United States 7 494 1.1× 482 1.2× 142 0.4× 259 1.1× 91 0.4× 7 1.4k
Alpana Ray United States 23 917 2.1× 58 0.1× 318 0.9× 244 1.0× 89 0.4× 62 1.4k
Allen Frankfater United States 15 496 1.1× 70 0.2× 367 1.1× 230 0.9× 122 0.5× 28 870
Barbara Peter Austria 21 417 1.0× 186 0.5× 72 0.2× 119 0.5× 72 0.3× 48 1.1k

Countries citing papers authored by H R Williams

Since Specialization
Citations

This map shows the geographic impact of H R Williams's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H R Williams with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H R Williams more than expected).

Fields of papers citing papers by H R Williams

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H R Williams. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H R Williams. The network helps show where H R Williams may publish in the future.

Co-authorship network of co-authors of H R Williams

This figure shows the co-authorship network connecting the top 25 collaborators of H R Williams. A scholar is included among the top collaborators of H R Williams based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H R Williams. H R Williams is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Lark, Michael W., E K Bayne, Coral Harper, et al.. (1997). Aggrecan degradation in human cartilage. Evidence for both matrix metalloproteinase and aggrecanase activity in normal, osteoarthritic, and rheumatoid joints.. Journal of Clinical Investigation. 100(1). 93–106. 387 indexed citations
2.
Singer, Irwin, D W Kawka, E K Bayne, et al.. (1995). VDIPEN, a metalloproteinase-generated neoepitope, is induced and immunolocalized in articular cartilage during inflammatory arthritis.. Journal of Clinical Investigation. 95(5). 2178–2186. 108 indexed citations
3.
Lark, Michael W., H R Williams, Jeffrey R. Weidner, et al.. (1995). Quantification of a matrix metalloproteinase-generated aggrecan G1 fragment using monospecific anti-peptide serum. Biochemical Journal. 307(1). 245–252. 57 indexed citations
4.
Martin, Mary M., John Leszyk, Jeffrey R. Weidner, et al.. (1994). Inhibition of calcineurin by a novel FK-506-binding protein.. Journal of Biological Chemistry. 269(33). 21094–21102. 72 indexed citations
5.
Kuo, David, Hak‐Kim Chan, Carol J. Wilson, et al.. (1993). Escherichia coli Leader Peptidase: Production of an Active Form Lacking a Requirement for Detergent and Development of Peptide Substrates. Archives of Biochemistry and Biophysics. 303(2). 274–280. 54 indexed citations
6.
Nicoll‐Griffith, Deborah A., et al.. (1992). In vitro and in vivo biotransformations of the potent leukotriene D4 antagonist verlukast in the rat.. Drug Metabolism and Disposition. 20(3). 383–389. 7 indexed citations
8.
Jones, Thomas R., Robert Zamboni, Michel Belley, et al.. (1989). Pharmacology of L-660,711 (MK-571): a novel potent and selective leukotriene D4 receptor antagonist. Canadian Journal of Physiology and Pharmacology. 67(1). 17–28. 232 indexed citations
9.
Navia, Manuel A., Brian M. McKeever, James P. Springer, et al.. (1989). Structure of human neutrophil elastase in complex with a peptide chloromethyl ketone inhibitor at 1.84-A resolution.. Proceedings of the National Academy of Sciences. 86(1). 7–11. 205 indexed citations
10.
Spates, George E., Marcel H. Elissalde, & H R Williams. (1988). Lipid composition of housefly microsomes. Archives of Insect Biochemistry and Physiology. 7(1). 47–57. 2 indexed citations
11.
Williams, H R, Tsau-Yen Lin, Manuel A. Navia, James P. Springer, & Karst Hoogsteen. (1987). Pig pancreatic anhydro-elastase. Role of the serine-195 hydroxy group in the binding of inhibitors and substrate. Biochemical Journal. 242(1). 267–273. 3 indexed citations
12.
Williams, H R, Tsau-Yen Lin, Manuel A. Navia, et al.. (1987). Crystallization of human neutrophil elastase.. Journal of Biological Chemistry. 262(35). 17178–17181. 12 indexed citations
13.
Lin, Tsau-Yen & H R Williams. (1979). Inhibition of cathepsin D by synthetic oligopeptides.. Journal of Biological Chemistry. 254(23). 11875–11883. 20 indexed citations
14.
Fletcher, D., H R Williams, & Tsau-Yen Lin. (1978). Effects of human polymorphonuclear leukocyte collagenase on sub-component C1q of the first component of human complement. Biochimica et Biophysica Acta (BBA) - General Subjects. 540(2). 270–277. 7 indexed citations
15.
Lin, Tsau-Yen & H R Williams. (1975). Inhibition of the local hemorrhagic Shwartzman reaction by an acid proteinase inhibitor, pepstatin. Cellular and Molecular Life Sciences. 31(2). 209–212. 4 indexed citations
16.
Hostetler, Karl Y., H R Williams, Walton W. Shreeve, & Bernard R. Landau. (1969). Conversion of Specifically 14C-Labeled Lactate and Pyruvate to Glucose in Man. Journal of Biological Chemistry. 244(8). 2075–2077. 32 indexed citations
17.
Smith, H J & H R Williams. (1967). A partition theory for the action of quaternary ammonium compounds at the muscarinic receptor site. Journal of Theoretical Biology. 14(2). 218–224. 7 indexed citations
18.
Blanchaer, M. C., et al.. (1955). Presence of the Glycolytic Enzymes D-Glyceraldehyde-3-Phosphate Dehydrogenase Phosphoglycerate Kinase and Triosephosphate Isomerase in Hemolysates of Preserved Blood. American Journal of Physiology-Legacy Content. 181(3). 602–608. 7 indexed citations
19.
Blanchaer, M. C., et al.. (1955). Decreased Phosphofructokinase Activity in Preserved Blood. American Journal of Physiology-Legacy Content. 183(1). 95–97. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026